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Autosomal recessive; frequency is about 2/105 
newborns in Ashkenazi Jews and in the Japanese 
(founder effect: affected persons descent from a 





168 cases have been registered in the Bloom's 
syndrome Registry by James German; BS patients are 
predisposed to all types of cancer observed in the 
general population; thus, BS is a model of initiation and 
promotion of cancer, and highligths internal 
causes/processes of cancers. 
 
Micronuclei (left); sister chromatid exchange (right) in a normal subject (herein: 19 SCE, instead of the hundred found in Bloom, see 
below) – Editor. 
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Phenotype and clinics 
- Phenotypic spectrum variable. 
- Growth: dwarfism: intrauterine growth retardation; 
birth weight: below 2.3 kg; mean length: 44 cm; adult 
length < 145 cm. 
- Skin: hyperpigmented (café au lait) spots; 
hypopigmented areas; sun sensitive telangiectatic 
erythema; in butterfly configuration across the face: 
resembles lupus erythematous. 
- Head: microcephaly; dolichocephaly; narrow face; 
prominent nose and/or ears; characteristic high-pitched 
voice. 
- Normal intelligence. 
- Immune deficiency --> frequent infections (may be 
life-threatening). 
- Other: myocardopathy; hypogonadism in male 
patients; hypertriglyceridemia. 
Neoplastic risk 
Nearly half of patients have had at least one cancer 
(10% of whom having had more than one primary 
cancer, which is quite characteristic of Bloom's); mean 
age at first cancer onset: 25 yrs (range: 2-49 yrs).
Acute leukaemias (ALL and ANLL) in 15 % of cases; 
lymphomas in 15 % as well; these occur mainly before 
the thirties. 
Carcinomas (of a wide variety) occur in 30 % of cases, 
mainly after the age of 20 yrs. 
Benign tumours (10%). 
Evolution 
Major medical complications apart from cancers are: 
chronic lung disease, and diabetes mellitus (in 10 %). 
Prognosis 
1/3 of patients are dead at mean age 24 yrs (oldest di d 
at 49 yrs, youngest died before 1 yr) and the mean age 




Chromatid/chromosome breaks; triradial and 
quadriradial figures, in particular symetrical 
quadriradial configuration involving homologous 
chromosomes (Class I qr), which are pathognomonic 
and which may be due to a mitotic crossing-over; 
micronuclei. 
Diagnosis is on the (pathognomonic) highly elevated 
spontaneous sister chromatid exchange rate (90 SCE 
per cell; more than 10 times what is normally found); in 
some persons a minor population of low SCE cells 
exists, suggesting a recombination event between 
maternal and paternal alleles (with different mutations), 
giving rise to a wild type functional gene; this allowed 
to localize the gene in a very elegant strategy. 




Slowing of the cell cycle (lenthening of the G1 and S 
phases). 
Spontaneous mutation rate 10 times higher than normal 
cells. 
 
Sister chromatid exchange in a normal subject (left) and in a Bloom syndrome patient (right) (from: Mounira Amor-Guéret). 
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Genes involved and proteins 
Complemantation groups 





Description: 1417 amino acids; contains one ATP 
binding site, one DEAH box, and two putative nuclear 
localization signals. 
Expression: Accumulates to high levels in S phase of 
the cell cycle, persists in G2/M and sharply declines in 
G1; hyperphoshorylated in mitosis. 
Localisation: Nuclear (PML nuclear bodies and 
nucleolus). 
Function: 3-5 DNA helicase; probable role in DNA 
replication and double-strand break repair. 
Preferred substrates: G-quadruplex DNA, D-loops 
structures and X-junctions. Recombinant protein 
promotes ATP-dependent branch migration of 
Hollyday junctions. 
Participates in a supercomplex of BRCA1-associated 
proteins named BASC (BRCA1-Associated genome 
Surveillance Complex) and in a complex named 
BRAFT (BLM, RPA, FA, Topoisomerase IIIalpha) 
containing five of the Fanconia Anemia (FA) 
complementation group proteins (FANCA, FANCG, 
FANCC, FANCE and FANCF). 
Interacts physically and/or functionally with p53, 
53BP1, WRN, MLH1, RAD51, TRF2, ligase IV, FEN1 
Associated with telomeres and ribosomal DNA repeats. 
Phosphorylated in mitotic cells through the cdc2 
pathway, and in response to DNA damaging agents. 
Homology: With the RecQ helicases. 
Mutations 
Germinal: Five BLM mutations introducing amino acid 
substitutions and four BLM mutations introducing 
premature nonsense codons into the coding sequence 
have been described to date; one BLM mutation 
consisting in a 6 bp deletion accompanied by a 7 bp 
insertion at nucleic acid position 2281 is common in 
patients from Ashkenazi Jewish ancestry, leading to a
truncated protein of 739 amino acids in length; two 
BLM mutations, 631delCAA and 1610insA were 
detected in japanese patients. 
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